Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

Filing 448

ORDER by Judge Haywood S. Gilliam, Jr. Granting 447 Stipulation Regarding Trial Re Docket No. 446 . Pretrial Conference set for 6/8/2021 03:00 PM before Judge Haywood S. Gilliam Jr. and Jury Selection /Jury Trial (2-week) set for 7/12/2021 08:30 AM before Judge Haywood S. Gilliam Jr. (ndrS, COURT STAFF) (Filed on 1/15/2021)

Download PDF
1 2 3 4 5 6 7 8 9 11 ATTORNEYS AT LAW M C D ERMOTT W ILL & E MERY LLP 10 12 13 14 15 16 17 18 THOMAS P. STEINDLER (Pro Hac Vice) tsteindler@mwe.com PAUL M. SCHOENHARD (Pro Hac Vice) pschoenhard@mwe.com MICHAEL S. NADEL (Pro Hac Vice) mnadel@mwe.com IAN B. BROOKS (Pro Hac Vice) ibrooks@mwe.com JENNIFER ROUTH (Pro Hac Vice) jrouth@mwe.com DAVID MLAVER (Pro Hac Vice) dmlaver@mwe.com MCDERMOTT WILL & EMERY LLP 500 N. Capitol St., N.W. Washington, DC 20001 Tel: (202) 756-8000 Fax: (202) 756-8087 WILLIAM G. GAEDE III (SBN: 136184) wgaede@mwe.com MCDERMOTT WILL & EMERY LLP 275 Middlefield Road, Suite 100 Menlo Park, CA 94025 Tel: (650) 815-7400 Fax: (650) 469-1470 SARAH CHAPIN COLUMBIA (Pro Hac Vice) scolumbia@mwe.com MCDERMOTT WILL & EMERY LLP 200 Clarendon Street, Floor 58 Boston, MA 02116-5021 Tel: (617) 535-4074 Fax: (617) 535-3800 Attorneys for Defendant Novartis Pharmaceuticals Corporation 19 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION 20 21 PLEXXIKON INC., CASE NO. 4:17-cv-04405-HSG 22 Plaintiff, JOINT STIPULATION REGARDING TRIAL; ORDER 23 v. 24 25 26 Ctrm: 2 – 4th Floor Judge: Honorable Haywood S. Gilliam, Jr. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant. 27 28 -1- JOINT STIPULATION REGARDING TRIAL CASE NO. 4:17-CV-04405-HSG 1 Plaintiff Plexxikon Inc. (“Plaintiff”) and Defendant Novartis Pharmaceuticals Corporation 2 (“Defendant”) (collectively, “the Parties”) by and through their respective counsel of record, 3 hereby stipulate and request as follows: 4 WHEREAS, the Parties are prepared to proceed with a jury trial on July 12, 2021, subject 5 6 to health and safety concerns as may exist at that time; and 7 WHEREAS, the Plaintiff is not prepared to waive its right to a jury trial at this time; 8 NOW, THEREFORE, the Parties stipulate and agree as follows: 9 A two-week jury trial will be held in the above-captioned case beginning on July 12, 11 ATTORNEYS AT LAW M C D ERMOTT W ILL & E MERY LLP 10 2021. The pre-trial conference will be held on June 8, 2021 at 3 p.m. 12 13 14 Dated: January 14, 2021 Respectfully submitted, 15 McDERMOTT WILL & EMERY LLP 16 17 By: /s/ Thomas P. Steindler Thomas P. Steindler 18 Attorneys For Defendant Novartis Pharmaceuticals Corporation 19 20 Dated: January 14, 2021 Respectfully submitted, 21 DURIE TANGRI LLP 22 23 By: /s/ Daralyn J. Durie Daralyn J. Durie 24 Attorneys For Plaintiff Plexxikon, Inc. 25 26 27 28 -2- JOINT STIPULATION REGARDING TRIAL CASE NO. 4:17-CV-04405-HSG 1 FILER’S ATTESTATION 2 3 Pursuant to Civil L. R. 5-1(i)(3), the undersigned attests that all parties have concurred in the filing of this document. 4 Dated: January 14, 2021 Respectfully submitted, 5 McDERMOTT WILL & EMERY LLP 6 7 By: /s/ Thomas P. Steindler Thomas P. Steindler 8 Attorneys For Defendant Novartis Pharmaceuticals Corporation 9 11 ATTORNEYS AT LAW M C D ERMOTT W ILL & E MERY LLP 10 12 ORDER PURSUANT TO STIPULATION, IT IS SO ORDERED 13 14 15 Dated: 1/15/2021 By: HAYWOOD S. GILLIAM, JR. United States District Judge 16 17 18 19 20 21 22 23 24 25 26 27 28 -3- JOINT STIPULATION REGARDING TRIAL CASE NO. 4:17-CV-04405-HSG

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?